Skip to content

The effect of tacrolimus ointment and timolol solution in the treatment of post-acne erythema

Comparison of the effect of 0.1% tacrolimus ointment with 0.5% timolol solution in the treatment of Post Acne erythema

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151123025202N33
Enrollment
86
Registered
2023-10-27
Start date
2023-11-22
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris. Acne vulgaris

Interventions

Intervention 1: Intervention group: Tacrolimus ointment 0.1% will be used topically once a night for 8 weeks. Intervention 2: Intervention group: 0.5% timolol maleate solution will be used topically o

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age above 18 years Consent to participate in the study

Exclusion criteria

Exclusion criteria: History of allergy to tacrolimus and timolol History of using anti-acne drugs within 3 months before the treatment process Pregnant and lactating mothers bronchial asthma, severe COPD, sinus bradycardia, 2nd and 3rd degree heart block and heart failure

Design outcomes

Primary

MeasureTime frame
Erythema. Timepoint: Before treatment, at the end of week 4 and at the end of week 8 of treatment. Method of measurement: Take a picture of lesions and and compare based on Clinical Erythema Assessment scale by dermatologist.

Secondary

MeasureTime frame
Side effects of itching, burning, scaling and redness. Timepoint: 4th and 8th week of treatment. Method of measurement: Clinical examination and asking the patient about complications.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Moradi

Hamedan University of Medical Sciences

a.moradi@umsha.ac.ir+98 81 3838 0557

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026